Top

Published in:

01-12-2020 | Breast Cancer | Commentary

Metabolomics and breast cancer: scaling up for robust results

Author: Steven C. Moore

Published in: BMC Medicine | Issue 1/2020

Excerpt

Breast cancer is the most commonly diagnosed cancer among women, with more than 2 million new cases diagnosed in 2018 [1], and rapidly rising global incidence. Though breast cancer has been extensively studied, established risk factors explain only half of breast cancer incidence [2], and few are modifiable. Identifying further risk factors is urgently needed to inform cancer control strategies to slow the rise in the rate of breast cancer. New ‘omics-based approaches to exposure measurement may enable hundreds to thousands of novel exposures to be evaluated simultaneously, often in pathways that would otherwise be unstudied. …

Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424.PubMed

Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50302 women with breast cancer and 96973 women without the disease. Lancet. 2002;360:187–95.CrossRef

His M, Viallon V, Dossus L, Gicquiau A, Achaintre D, Scalbert A, et al. Prospective analysis of circulating metabolites and breast cancer in EPIC. BMC Med. 2019;17:178.CrossRefPubMedPubMedCentral

World Cancer Research Fund, American Institute for Cancer Research. Diet, nutrition, physical activity and breast cancer: a global perspective. Continuous Update Project Expert Report 2018. https://www.https://www.wcrf.org/dietandcancer. Accessed 17 Dec 2019.

Bene J, Hadzsiev K, Melegh B. Role of carnitine and its derivatives in the development and management of type 2 diabetes. Nutr Diabetes. 2018;8:8.CrossRefPubMedPubMedCentral

Carracedo A, Cantley LC, Pandolfi PP. Cancer metabolism: fatty acid oxidation in the limelight. Nat Rev Cancer. 2013;13:227–32.CrossRefPubMedPubMedCentral

Kühn T, Floegel A, Sookthai D, Johnson T, Rolle-Kampczyk U, Otto W, et al. Higher plasma levels of lysophosphatidylcholine 18:0 are related to a lower risk of common cancers in a prospective metabolomics study. BMC Med. 2016;14:13.CrossRefPubMedPubMedCentral

Lécuyer L, Victor Bala A, Deschasaux M, , Bouchemal N, Nawfal Triba M, Vasson MP, et al. NMR metabolomic signatures reveal predictive plasma metabolites associated with long-term risk of developing breast cancer. Int J Epidemiol 2018;47:484–494.CrossRefPubMed

Moore SC, Playdon MC, Sampson JN, Hoover RN, Trabert B, Matthews CE, et al. A metabolomics analysis of body mass index and postmenopausal breast cancer risk. J Natl Cancer Inst. 2018;110:588–97.PubMedPubMedCentral

10.

Wang TJ, Larson MG, Vasan RS, Cheng S, Rhee EP, McCabe E, et al. Metabolite profiles and the risk of developing diabetes. Nat Med. 2011;17:448–53.CrossRefPubMedPubMedCentral

Title: Metabolomics and breast cancer: scaling up for robust results
Author: Steven C. Moore
Publication date: 01-12-2020
Publisher: BioMed Central
Keywords: Breast Cancer
Breast Cancer
Published in: BMC Medicine / Issue 1/2020
Electronic ISSN: 1741-7015
DOI: https://doi.org/10.1186/s12916-019-1484-5

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Metabolomics and breast cancer: scaling up for robust results

Excerpt

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2020

New insights into genetic susceptibility of COVID-19: an ACE2 and TMPRSS2 polymorphism analysis

Clinical outcomes in patients with atrial fibrillation and frailty: insights from the ENGAGE AF-TIMI 48 trial

Are environmental area characteristics at birth associated with overweight and obesity in school-aged children? Findings from the SLOPE (Studying Lifecourse Obesity PrEdictors) population-based cohort in the south of England

Patient and public involvement in research: from tokenistic box ticking to valued team members

Raising awareness of antimicrobial resistance: comment on ‘Reducing expectations for antibiotics in primary care: a randomised experiment to test the response to fear based messages about antimicrobial resistance’

A systematic review of changing malaria disease burden in sub-Saharan Africa since 2000: comparing model predictions and empirical observations